Publications
2025
Statin Use in Patients With Cancer: Drug Interaction and Statin Usage. JACC: Advances. PMID: 41124987
Immune checkpoint inhibitor-associated myocarditis: a novel risk score. European Heart Journal. PMID: 40569849
2024
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. PMID: 39239327
Acute radiation-induced pericarditis complicated by polymicrobial infectious pericarditis in a patient with mediastinal sarcoma: a case report. Eur Heart J Case Rep. PMID: 38405193
Left atrial strain is reduced following trastuzumab in breast cancer patients. Echocardiography. PMID: 38284677
2023
Oxygen toxicity causes cyclic damage by destabilizing specific Fe-S cluster-containing protein complexes. Molecular Cell. PMID: 36893757
In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia response. Science Advances. PMID: 38064566
Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart Association. Circulation. PMID: 37377045.
Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report. Cardiooncology. PMID: 37908018
2022
Hypoxia signaling and oxygen metabolism in cardio-oncology. J Mol Cell Cardiol. PMID: 34979102.
2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol. PMID: 34232253.
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. Circulation Research. PMID: 33934609
Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors. Clin Sci (Lond). PMID: 33686402
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. Circ Res. PMID: 33934611
2020
Turning the Oxygen Dial: Balancing the Highs and Lows. Trends Cell Biol. PMID: 32386878
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!